BETTY RYBA: Open Payments
NPI 1346433430 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$122 in 6 payments from 4 companies in 2025. Trend: 2023 $243 · 2024 $301 · 2025 $122
Food & beverage: $122
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
| PFIZER INC. | 1 | $21 |
Products named: XIFAXAN, GVOKE HYPOPEN, Wegovy, NURTEC ODT.
Industry payments across MS — which companies pay providers there.
